Drug compatibilities and infusion sites
Maguire, D.
Neonatal Network Nn 13(4): 79-80
1994
ISSN/ISBN: 0730-0832 PMID: 8007929 Document Number: 423593
Many medications commonly used in the NICU are compatible, but are not routinely coinfused. By minimizing infusion sites, nurses contribute to protecting our smallest patients against infection and stress. No single handbook or resource provides comprehensive information about drug compatibilities. Clinicians must cross-reference several sources to guide their practice.
Document emailed within 1 workday
Related Documents
Zachrisson, U.; Fürst, C.J. 1995: A survey of drug administration via infusion pumps. Morphine is the most frequently used drug administered by infusion pump Lakartidningen 92(49): 4686-4688Itano, S.; Hirai, K.; Kajiwara, M.; Ijuin, H.; Yoshiyama, Y.; Yoshida, T.; Sakata, K.; Ono, N.; Noguchi, H.; Sakai, T. 1994: A study of the drug distribution on intra-hepatic arterial infusion chemotherapy; how much difference between continuous infusion and rapid infusion? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(13): 2136-2139
Phillips, D.R.; White, R.J.; Trist, H.; Cullinane, C.; Dean, D.; Crothers, D.M. 1990: New insight into drug-DNA interactions at individual drug binding sites probed by RNA polymerase during active transcription of the DNA Anti-Cancer Drug Design 5(1): 21-29
Gopalani, V. 2005: Web sites on adverse drug reactions and drug interactions Indian Journal of Dermatology Venereology and Leprology 71(1): 60-62
Blumenthal, S.; Borgeat, A. 2007: Continuous infusion of local anesthetic at iliac crest bone-graft sites for postoperative pain relief Journal of Bone and Joint Surgery. American Volume 89(5): 1133; Author Reply 1133-4
Peng, W.; Jiang, Y-Ping.; Fu, C-Mei.; Gao, F.; Yang, H.; Liu, G-Yi.; Yu, J-Li. 2015: Changing rules study of effective components of Glycyrrhizae Radix et Rhizoma before and after compatibilities in Sini decoction Zhongguo Zhong Yao Za Zhi 40(1): 84-88
Müller, W.E. 1989: Drug binding sites on human alpha-1-acid glycoprotein Progress in Clinical and Biological Research 300: 363-378
Sudlow, G.; Birkett, D.J.; Wade, D.N. 1975: The characterization of two specific drug binding sites on human serum albumin Molecular Pharmacology 11(6): 824-832
Ei-Fakahany, E.F.; Miller, E.R.; Abbassy, M.A.; Eldefrawi, A.T.; Eldefrawi, M.E. 1983: Alcohol modulation of drug binding to the channel sites of the nicotinic acetylcholine receptor Journal of Pharmacology and Experimental Therapeutics 224(2): 289-296
Ottesen, S.; Manger, A.T.; Monrad, L. 1992: Continuous drug infusion in terminal cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(14): 1836-1839
Kowaluk, E.A.; Roberts, M.S.; Polack, A.E. 1983: Drug loss in polyolefin infusion systems American Journal of Hospital Pharmacy 40(1): 118-119
Li Dapeng 2005: The anticancer drug Kang-Lai-Te emulsion for infusion Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2005(9): 32-37
Loewenstein-Lichtenstein, Y.; Glick, D.; Gluzman, N.; Sternfeld, M.; Zakut, H.; Soreq, H. 1996: Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis Molecular Pharmacology 50(6): 1423-1431
Breukels, O.; van der Gronde, T.; Simons-Sanders, K.; Crul, M. 2018: Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags International Journal of Pharmaceutical Compounding 22(4): 345-349
Nguyen, H.T.; Duc, N.B.; Shrivastava, R.; Tran, T.H.; Nguyen, T.A.; Thang, P.H.; McNicholl, J.M.; Leelawiwat, W.; Chonwattana, W.; Sidibe, K.; Fujita, M.; Luu, C.M.T.; Kakkar, R.; Bennett, D.E.; Kaplan, J.; Cosimi, L.; Wolfe, M.I. 2008: HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam Antiviral Therapy 13(Suppl 2): 115-121
Ge, L.; Cui, Y.; Wang, L.; Li, D.; Guo, W.; Ding, Z.; Wang, L. 2014: Study on the characteristics of serology and sexual behavior among drug users at the HIV sentinel surveillance sites in 2012 Zhonghua Liu Xing Bing Xue Za Zhi 35(2): 121-123
Jordan, M.R.; Bennett, D.E.; Bertagnolio, S.; Gilks, C.F.; Sutherland, D. 2008: World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites Antiviral Therapy 13 Suppl. 2: 15-23
Shelegiia, S.I.; Kvernadze, M.G.; Mosidze, M.A.; Abesadze, A.I. 1986: Mechanism of action of a mass infusion of thrombocytes in experimental drug-induced thrombocytopenia Gematologiia i Transfuziologiia 31(3): 23-27
Tanaka, T.; Sakaguchi, H.; Anai, H.; Kichikawa, K. 2006: Drug distribution and alteration of blood flow for pancreatic arterial infusion chemotherapy Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 264-269
Listgarten, M.A. 1984: Subgingival microbiological differences between periodontally healthy sites and diseased sites prior to and after treatment International Journal of Periodontics and Restorative Dentistry 4(1): 27-34